NEA Management Company’s X4 Pharmaceuticals XFOR Stock Holding History

NEA Management Company’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Hold	3,233,743	–	–	0.76%	16
2025 Q4	$12.9M	Buy	3,233,743 +1,000,000	+45%	+$3.63M	0.66%	16
2025 Q3	$7.64M	Buy	2,233,743 +1,734,184	+347%	+$4.47M	0.42%	23
2025 Q2	$949K	Sell	499,559 -1	-0%	-$4	0.07%	30
2025 Q1	$3.54M	Hold	499,560	–	–	0.27%	29
2024 Q4	$11M	Hold	499,560	–	–	0.62%	22
2024 Q3	$10M	Hold	499,560	–	–	0.55%	28
2024 Q2	$8.69M	Hold	499,560	–	–	0.65%	28
2024 Q1	$20.8M	Hold	499,560	–	–	1.29%	17
2023 Q4	$12.6M	Hold	499,560	–	–	0.84%	23
2023 Q3	$16.3M	Hold	499,560	–	–	1.26%	18
2023 Q2	$29.1M	Buy	499,560 +108,334	+28%	+$5.57M	2.22%	14
2023 Q1	$10.2M	Hold	391,226	–	–	0.71%	28
2022 Q4	$11.7M	Buy	391,226 +173,787	+80%	+$8.23M	0.65%	27
2022 Q3	$11.2M	Buy	+217,439	New	+$7.51M	0.56%	33
2020 Q2	–	Sell	-11,111	Closed	-$3.33M	–	47
2020 Q1	$3.33M	Hold	11,111	–	–	0.17%	44
2019 Q4	$3.57M	Hold	11,111	–	–	0.17%	40
2019 Q3	$4.24M	Hold	11,111	–	–	0.35%	36
2019 Q2	$5M	Hold	11,111	–	–	0.35%	33
2019 Q1	$5.8M	Hold	11,111	–	–	0.3%	36
2018 Q4	$4.64M	Hold	11,111	–	–	0.18%	37
2018 Q3	$3.24M	Hold	11,111	–	–	0.14%	41
2018 Q2	$7.26M	Hold	11,111	–	–	0.34%	36
2018 Q1	$45.8M	Hold	11,111	–	–	2.04%	13
2017 Q4	$25.5M	Buy	+11,111	New	+$28.1M	1.06%	22

Other funds holding XFOR

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NEA Management Company's XFOR Position: Q1 2026 in Review

NEA Management Company held its X4 Pharmaceuticals (XFOR) position steady in Q1 2026 at 3,233,743 shares worth $13.4M. The position accounts for 0.76% of the portfolio, ranked #16.

NEA Management Company first reported a position in XFOR in Q4 2017 and has held it in 25 quarters since. The position peaked at $45.8M in Q1 2018. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

NEA Management Company held 3,233,743 shares of X4 Pharmaceuticals worth $13.4M as of Q1 2026.
NEA Management Company left its X4 Pharmaceuticals share count unchanged in Q1 2026.
X4 Pharmaceuticals made up 0.76% of NEA Management Company's portfolio in Q1 2026, its #16 holding.
NEA Management Company first reported a position in X4 Pharmaceuticals in Q4 2017 and has held it in 25 quarters since.
NEA Management Company's X4 Pharmaceuticals position peaked at $45.8M in Q1 2018.
84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.